CISO Tribune

Vendor comparison · 2 companies

BioCatch vs TransUnion

BioCatch sells BioCatch Connect, a fraud and financial crime platform that unites real-time telemetry, behavioral analysis, and predictive intelligence to detect and prevent account opening fraud, account takeover, social engineering scams, and mule accounts. TransUnion offers secure, on-demand access to TransUnion data and analytics. CISO Tribune files both under Fraud prevention. This page sets the two records side by side: what each sells, where it is based, who owns and funds it, the customers it names and its recent news, each fact numbered to its source.

Change the companies

Up to four companies side by side.

  • BioCatch
  • TransUnion
BioCatch vs TransUnion: Products, Customers and Funding Compared
BioCatchBioCatch sells BioCatch Connect, a fraud and financial crime platform that unites real-time telemetry, behavioral analysis, and predictive intelligence to detect and prevent account opening fraud, account takeover, social engineering scams, and mule accounts.biocatch.comTransUnionTransUnion offers secure, on-demand access to TransUnion data and analytics.transunion.com
What it sells
  • BioCatch Connect[1][3][4]A fraud and financial crime platform that unites real-time telemetry, behavioral analysis, and predictive intelligence.
  • BioCatch Trust[7]An inter-bank, real-time financial-crime intelligence network that unites financial institutions against fraud and money laundering.
  • TruValidate[1][7][8]Orchestrates identity, device and behavioral insights to help organizations interact with legitimate consumers while mitigating fraud risk.
  • TruValidate Device Risk[8]Determines the reputation of a device from device history and confirmed fraud reports, in real time.
  • TruAudience[10][11][12]Marketing and measurement built on identity resolution, data enrichment, audience targeting and analytics.
Categories
Headquarters
Not stated on its pagesNot stated on its pages
Founded
Not stated on its pagesNot stated on its pages
Ownership and funding
Not stated on its pagesPublic (NYSE: TRU)[2][4][5][9]
Named customers
Not stated on its pagesNot stated on its pages
Recent news
Not stated on its pagesNot stated on its pages
G2 and Gartner Peer Insights
  • G2: listed, seen November 10, 2026[11]
  • Gartner Peer Insights: Not stated on its pages
  • G2: listed, seen November 10, 2026[5]
  • Gartner Peer Insights: Not stated on its pages
Who it fits
From its own pages, BioCatch sells mainly to banks and other financial institutions. BioCatch Connect is described for financial service organizations, and BioCatch Trust connects member banks that share intelligence on suspicious receiving accounts. BioCatch addresses fraud, AML, and cybersecurity teams.TruValidate is aimed at organizations that interact with consumers over call center and digital channels. The fraud solutions address organizations protecting new account creation and account access. TruAudience is aimed at organizations running data-driven marketing and measurement programs. For individual consumers, TransUnion offers a free fraud alert, a credit freeze and credit dispute tools.
Last verified
November 2, 2026October 14, 2026

Where they overlap

  • Fraud prevention is the primary category of both BioCatch and TransUnion.

Where they differ, field by field

  • TransUnion is also filed under Identity verification.
  • BioCatch lists BioCatch Connect and BioCatch Trust. TransUnion lists TruValidate, TruValidate Device Risk and TruAudience.
  • TransUnion is a public company listed on NYSE as TRU.

How they differ

CISO Tribune files both BioCatch and TransUnion under Fraud prevention as the primary category, and TransUnion is also filed under Identity verification. BioCatch sells BioCatch Connect, a fraud and financial crime platform that combines real-time telemetry, behavioral analysis and predictive intelligence, and BioCatch Trust, an inter-bank financial-crime intelligence network. TransUnion sells TruValidate, which orchestrates identity, device and behavioral insights, along with TruValidate Device Risk and TruAudience, a marketing and measurement product built on identity resolution.

The overlap sits in behavioral and device signals: BioCatch applies behavioral biometrics and a device offering, while TruValidate Device Risk rates a device from its history and confirmed fraud reports. BioCatch sells mainly to banks and other financial institutions, and its fraud, AML and cybersecurity teams are its stated audience. TruValidate applies to call center and digital channels, and TruAudience is aimed at organizations running data-driven marketing and measurement programs. TransUnion also offers consumers a free fraud alert and a free credit freeze.

BioCatch was founded in 2011 and has offices in Tel Aviv, London, New York City, São Paulo, Mexico City, Mumbai and Sydney. In 2019, BioCatch acquired AimBrain and secured a $145 Million investment from Bain Capital. TransUnion is a public company listed on NYSE as TRU. BioCatch has more than 100 customers across more than 20 countries, and HSBC has spoken of its partnership with BioCatch. In May 2025, Banco Galicia, Naranja X and Santander joined BioCatch Trust Argentina.

What it sells: BioCatch

What BioCatch Connect does[1][3][4]
BioCatch Connect detects and prevents account opening fraud, account takeover, social engineering scams, and mule accounts. BioCatch Connect continuously analyzes thousands of applications, behavioral, device, network, and transactional signals. BioCatch Connect is a collection of patented machine learning, behavioral science and advanced visualization technologies.
What BioCatch Trust does[7]
BioCatch Trust connects banks through a shared layer of behavioral, device, network, and transaction intelligence. BioCatch Trust assesses in real time the trustworthiness of the accounts to which member-bank customers direct transfers and payments. If the network flags a receiving account as suspicious, BioCatch Trust shares this intelligence with the sending bank in real time.

What it sells: TransUnion

What TruValidate does[1][7][8]
TruValidate verifies consumer identities against global datasets to expose fraud risks. TruValidate includes custom, purpose-built models that target unique or industry-specific fraud. TruValidate applies to call center and digital channels. TruValidate assesses the risk of fraud in anonymous digital interactions.
What TruValidate Device Risk does[8]
TruValidate Device Risk determines the reputation of a device from device history and confirmed fraud reports from a global network of fraud analysts, in real time. Device Risk covers customer touchpoints where fraud risk is a concern, including account creation, application, login, change of details, payment and check out.
What TruAudience does[10][11][12]
TruAudience powers data-driven marketing and measurement with identity resolution, data enrichment, audience targeting and advanced analytics solutions. TruAudience connects data, teams and marketing platforms with a single identity graph. TruAudience lets users search, buy and activate more than 130K off-the-shelf audiences to reach consumers across media types.

Questions about BioCatch and TransUnion

What do BioCatch and TransUnion sell?
BioCatch sells BioCatch Connect and BioCatch Trust. TransUnion sells TruValidate, TruValidate Device Risk and TruAudience.
Are BioCatch and TransUnion in the same category?
Yes. Fraud prevention is the primary category of both on CISO Tribune.
Who owns BioCatch and TransUnion?
TransUnion is a public company listed on NYSE as TRU.
Who are BioCatch and TransUnion sold to?
From its own pages, BioCatch sells mainly to banks and other financial institutions. TruValidate is aimed at organizations that interact with consumers over call center and digital channels.

About BioCatch

BioCatch sells BioCatch Connect, a fraud and financial crime platform that unites real-time telemetry, behavioral analysis, and predictive intelligence to detect and prevent account opening fraud, account takeover, social engineering scams, and mule accounts. BioCatch Connect continuously analyzes thousands of applications, behavioral, device, network, and transactional signals for financial service organizations. BioCatch Connect is a collection of patented machine learning, behavioral science and advanced visualization technologies. The science behind the BioCatch approach powers its Continuous Behavioral Sequencing (CBS) technology. BioCatch pairs multi-signal fraud telemetry with behavioral intelligence to give real-time context across every digital interaction.[3][4]

BioCatch says criminals have shifted their focus from systems to people, using coercion, manipulation, and social engineering to bypass controls. BioCatch applies behavioral biometrics to give financial institutions real-time insights for preventing fraud. BioCatch behavioral biometrics uses machine learning to analyze patterns in human behavior. BioCatch describes typing speed, swipe patterns, and mouse clicks as showing either cybercriminal activity or genuine user behavior. BioCatch use cases span origination, customer protection, financial crimes, device intelligence, and agentic AI.[3][5]

BioCatch describes an offering for account opening that analyzes every account opening interaction to distinguish genuine applicants from stolen identities, synthetic accounts, and mule activity. BioCatch describes an offering that continuously monitors sessions beyond the point of login to identify remote access, malware, and impersonation activity. BioCatch describes an offering that identifies mule activity by analyzing behavioral patterns, device intelligence, and network associations across the account lifecycle. BioCatch describes an offering that detects the cognitive behavioral signals of scam activity, including hesitation, confusion, and external pressure. BioCatch describes an offering that enables financial institutions to assess the trustworthiness of receiving accounts in real time before payments are completed, using a collaborative intelligence network that operates without sharing personally identifiable information. BioCatch describes a device offering that assesses whether a device can be trusted, identifying modified operating environments, remote access tools, and cross-institution device risk.[3]

BioCatch identifies signs of coercion and manipulation across both romance and investment scam scenarios. BioCatch treats hesitation during payment flows, longer press or click times, and rare typing patterns as suggesting uncertainty or external influence. For investment scams, BioCatch treats remote-access or screen-broadcasting activity, abnormal payment velocity, and crypto-related payment behavior as raising risk, particularly when combined with coaching signals. BioCatch uses intelligence from the user device, such as recent installs of dating, money transfer, and crypto apps, as indicative of a potential victim.[6]

BioCatch Trust is an inter-bank, real-time financial-crime intelligence network that unites financial institutions against fraud and money laundering. BioCatch Trust connects banks through a shared layer of behavioral, device, network, and transaction intelligence. BioCatch Trust protects member-bank customers against financial crime, fraud, and scams by assessing in real time the trustworthiness of the accounts to which they direct their transfers and payments. If the network flags a receiving account as suspicious, BioCatch Trust shares this intelligence with the sending bank in real time, so the institution can suspend and investigate the transaction before any money leaves the sender’s account. The four largest banks in Australia agreed to share intelligence in real time by joining BioCatch Trust Australia. In May 2025, Banco Galicia, Naranja X, and Santander joined BioCatch Trust Argentina. BioCatch Trust analyzes recipient-side patterns and network-level signals in real time to detect scams including BEC, romance, investment, and purchase. BioCatch Trust is built with hashed account identifiers, data masking, encryption, and strict role-based access controls. BioCatch Trust is compliant with GDPR, SOC 2 Type 2, and ISO 27001, and is overseen by a dedicated Data Protection Officer.[3][7]

BioCatch assigns a team of threat analysts, global advisors, and solutions engineers to each of its customers. BioCatch has a customer base of more than 100 that spans more than 20 countries. BioCatch addresses fraud, AML, and cybersecurity teams. HSBC states that it is looking forward to strengthening its partnership with BioCatch and to its role in the Client Innovation Board.[4][5][8][9]

BioCatch was founded in 2011 and focuses on online user behavior. Avi Turgeman first pursued the theory that people interact with machines in unique, measurable ways while serving in military intelligence. BioCatch has offices in Tel Aviv, London, New York City, São Paulo, Mexico City, Mumbai and Sydney. BioCatch technology is built on an IP portfolio of more than 60 granted patents. In 2019, BioCatch acquired AimBrain and secured a $145 Million investment from Bain Capital.[2][7]

BioCatch on the record

Sources

BioCatch full record

  1. [1]biocatch.comBioCatch · biocatch.com · undated page, accessed November 2, 2026 · Tier A
  2. [2]Biocatch to join visaBioCatch · biocatch.com · undated page, accessed November 2, 2026 · Tier A
  3. [3]BioCatch - Behavioral Intelligence to Prevent Fraud & Build TrustBioCatch · undated page, accessed November 10, 2026 · Tier A
  4. [4]Por Qué Elegir BioCatch | BioCatchBioCatch · undated page, accessed November 10, 2026 · Tier A
  5. [5]Behavioral Biometrics Solution | BioCatchBioCatch · undated page, accessed November 10, 2026 · Tier A
  6. [6]BioCatch - Use Case - Romance Investment ScamsBioCatch · undated page, accessed November 10, 2026 · Tier A
  7. [7]BioCatch Trust™BioCatch · undated page, accessed November 10, 2026 · Tier A
  8. [8]Why BioCatch | BioCatchBioCatch · undated page, accessed November 10, 2026 · Tier A
  9. [9]Why BioCatch | BioCatch - DEBioCatch · undated page, accessed November 10, 2026 · Tier A
  10. [10]The Leaders in Behavioral Biometrics | The BioCatch StoryBioCatch · undated page, accessed November 10, 2026 · Tier A
  11. [11]BioCatch Reviews 2026: Details, Pricing, & FeaturesG2 · undated page, accessed November 10, 2026 · Tier C

TransUnion full record

  1. [1]TruValidate | TransUnionTransUnion · undated page, accessed October 14, 2026 · Tier A
  2. [2]Transunion announces earnings release date for second quarter 2026 resultsTransUnion · newsroom.transunion.com · published June 30, 2026 · Tier A
  3. [3]About usTransUnion · transunion.com · undated page, accessed October 14, 2026 · Tier A
  4. [4]Solutions | TransUnionTransUnion · undated page, accessed November 2, 2026 · Tier A
  5. [5]Signal Reviews 2026: Details, Pricing, & Features | G2G2 · undated page, accessed November 2, 2026 · Tier C
  6. [6]Credit Solutions | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  7. [7]Fraud Solutions | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  8. [8]Digital Insights | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  9. [9]TruVision | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  10. [10]TruAudience | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  11. [11]Marketing Audiences | TruAudience | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  12. [12]Consumer and Marketing Insights | TruAudience | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  13. [13]Branded Communications | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A
  14. [14]Free Credit Score, Report, Monitoring & Alerts | TransUnionTransUnion · undated page, accessed November 10, 2026 · Tier A

Spot a factual error? Request a correction.